Events, talks and competitions to inspire you

Funding: Assessing the impact of medical technologies

Funding: Assessing the impact of medical technologies

UK SMEs can apply for a share of up to £1 million to evaluate innovative medical technologies that could help the NHS to meet its priorities.

The Office for Life Sciences, in partnership with Innovate UK, has up to £1 million to invest in projects that help developers of innovative medicines, medical devices, diagnostics and digital technologies to evaluate their products in a clinical setting.

This competition will allow small and medium-sized enterprises (SMEs) to generate evidence that the products they are developing can meet the priorities of the NHS. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.

All proposals must be business led and should:

  • describe the innovative medicine or CE-marked device
  • include any current up to date evidence of the product’s clinical performance and cost effectiveness
  • demonstrate how the product meets the priority needs defined in next steps on the NHS 5 year forward view, and how it is expected to deliver significant cost savings, health gains or beneficial service impacts, if quickly adopted across NHS England
  • provide evidence that you are working with appropriate stakeholders including the National Institute for Health and Care Excellence (NICE), NHS England, National Institute of Health Research (NIHR) and Academic Health Science Networks (AHSNs)
  • include the development or implementation of plans for data collection within the NHS
  • outline how studies will generate data on the costs and benefits of a product, allowing evaluation by NICE

For more information and to apply for this opportunity visit the gov.uk website.

Competition closes at 12pm on Wednesday 21st March 2018


Innovate UK’s open competition overcomes barriers to innovation. We provide funding for innovation-based enterprises. Such enterprises should demonstrate their readiness to deliver a project leading to new, highly innovative processes, products or services. Ideally these would result in successful commercialisation and/or significant, sustainable growth.

Get in touch

  • Submit